# Rivercell raises USD 25 million to build AI virtual cells and accelerate drug discovery

According to European Biotechnology, Rivercell raised USD 25 million on 10/7, led by HV Capital. It is building AI virtual cell models to digitalize key validation stages of drug discovery, aiming to shorten new drug development cycles and reduce early trial-and-error costs.



Canonical: https://uniquebase.ai/news/1957021d-5b50-4477-acb6-5eaa548d29ad
Stable identifier: 1957021d-5b50-4477-acb6-5eaa548d29ad
Snapshot captured: 2026-10-20T18:19:32.670Z
English updated: 2026-10-20T18:23:32.093Z

## Connected profiles

- [HV Capital](/institutions/hv-capital)
- [Rivercell](/companies/rivercell)

## Sources

- https://european-biotechnology.com/latest-news/rivercell-raises-25m-to-build-an-ai-virtual-cell/